Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).

Background: Chronic eosinophilic pneumonia (CEP) is characterized by the accumulation of eosinophils in the lung with unknown etiology. Although systemic corticosteroid administration leads to dramatic improvement, nearly half the patients with CEP experience relapse and some develop persistent impa...

Descripción completa

Detalles Bibliográficos
Publicado en:Annals of Allergy, Asthma & Immunology Vol. 119; no. 5; pp. 422 - 423
Autores principales: Suzuki, Yuzo, Oyama, Yoshiyuki, Hozumi, Hironao, Imokawa, Shiro, Toyoshima, Mikio, Yokomura, Koshi, Nakamura, Hidenori, Kuroishi, Shigeki, Karayama, Masato, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Koshimizu, Naoki, Yamada, Takashi, Mori, Kazutaka, Masuda, Masafumi, Shirai, Toshihiro, Hayakawa, Hiroshi
Formato: research Journal Article
Publicado: Elsevier B.V. Nov2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126230676&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 126230676
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10811206
        1FN
      jtl: Annals of Allergy, Asthma & Immunology
      issn: 10811206
      maglogo: N
    pubinfo:
      dt: Nov2017
      vid: 119
      iid: 5
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        126230676
        126230676
        NLM28942952
        126230676
        10.1016/j.anai.2017.08.009
        NLM28942952
        126230676
      ppf: 422
      ppct: 1
      formats:
      tig:
        atl: Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).
      aug:
        au:
          Suzuki, Yuzo
          Oyama, Yoshiyuki
          Hozumi, Hironao
          Imokawa, Shiro
          Toyoshima, Mikio
          Yokomura, Koshi
          Nakamura, Hidenori
          Kuroishi, Shigeki
          Karayama, Masato
          Furuhashi, Kazuki
          Enomoto, Noriyuki
          Fujisawa, Tomoyuki
          Nakamura, Yutaro
          Inui, Naoki
          Koshimizu, Naoki
          Yamada, Takashi
          Mori, Kazutaka
          Masuda, Masafumi
          Shirai, Toshihiro
          Hayakawa, Hiroshi
        affil: Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
      sug:
        subj:
          Lung Physiology
          Eosinophils Immunology
          Pulmonary Eosinophilia Diagnosis
          Asthma Epidemiology
          Glucocorticoids Therapeutic Use
          Pulmonary Eosinophilia Epidemiology
          Adult
          Male
          Female
          Spirometry
          Middle Age
          Pulmonary Eosinophilia Drug Therapy
          Prospective Studies
          Chronic Disease
          Aged, 80 and Over
          Aged
          Young Adult
          Prognosis
          Comorbidity
          Recurrence
          Prednisolone Therapeutic Use
          Japan
          Human
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged, 80 & over
          Aged: 65+ years
          Male
          Female
      ab: Background: Chronic eosinophilic pneumonia (CEP) is characterized by the accumulation of eosinophils in the lung with unknown etiology. Although systemic corticosteroid administration leads to dramatic improvement, nearly half the patients with CEP experience relapse and some develop persistent impairment of pulmonary function. However, predictive factors for this persistent impairment have not been determined.Objective: To investigate the occurrence of persistent impairment of pulmonary function in CEP and determine its predictive factors.Methods: This observational study consisted of 133 consecutive patients with CEP who were followed for longer than 1 year. Spirometry was performed at the time of diagnosis and at follow-up.Results: During the observational period (6.1 ± 4.1 years), relapse occurred in 75 patients (56.4%). Remarkably, 42 patients (31.6%) had a persistent pulmonary function defect (27 obstructive, 10 restrictive, and 4 obstructive and restrictive cases) at the last evaluation. Logistic analyses showed that the relapse was associated with neither persistent obstructive nor restrictive defects. Persistent obstructive defect was significantly associated with the comorbidity of asthma and obstructive defect at the initial CEP diagnosis, whereas persistent restrictive defect was significantly related to reticulation at high-resolution computer tomography and restrictive defect at diagnosis.Conclusion: Persistent impairment of pulmonary function is common in CEP. Concurrent asthma and obstructive defects at diagnosis were predictors for persistent obstructive impairments, whereas reticulation at high-resolution computer tomography and restrictive defect at diagnosis predicted persistent restrictive impairment. Attention should be paid to these persistent impairments in the management of CEP.Trial Registration: http://www.umin.ac.jp/ctr/index-j.htm Identifier: UMIN000019092 (principal investigator, Takafumi Suda, MD, PhD).
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N